As­traZeneca dis­putes IRA’s or­phan drug pro­vi­sions in lat­est le­gal chal­lenge to the law

As­traZeneca is the lat­est phar­ma com­pa­ny to chal­lenge the In­fla­tion Re­duc­tion Act in court, this time ze­ro­ing in on the law’s pro­vi­sions around or­phan drugs …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.